Kristi Rosa, Editorial Director, OncLive at MJH Life Sciences, shared a post on LinkedIn:
“Although I will not physically be heading to Berlin this year, I am counting down the days to this year’s ESMO – European Society for Medical Oncology Congress (ESMO25)! The excitement surrounding this meeting is tangible, and with so many pivotal trial readouts expected, how could it not be?
Over the past few weeks, the OncLive team has been busy interviewing several experts to see which presentations they are most excited to learn more about.
Which data are practice-changing? What approaches coming down the pike are anticipated to shake up treatment paradigms over the next few years? What research efforts are shifting standards and generating conversation?
Over the next few days, I will be spotlighting these exclusive previews in case you may have missed them. Today, we will start with lung cancer.
A special thank you to the following experts for taking the time to share their thoughts with us:
Sagus Sampath, Balazs Halmos, D. Ross Camidge, Edward B. Garon, Amol Akhade.
Read the exclusive preview now.”
More posts featuring ESMO25 on OncoDaily.